Literature DB >> 22196048

Correlation between EGFR Y1068 tyrosine phosphorylation and AP-1 activation by tumor promoter 12-O-tetradecanoylphorbol-13-acetate in mouse skin.

Michał Cichocki1, Mateusz Szamałek, Miłosz Dałek, Wanda Baer-Dubowska.   

Abstract

The mouse skin carcinogenesis is unique model for our understating of molecular events leading to tumor development. The tumor promoter, 12-O-tetradecanoylphorbol-13-acetate (TPA) activates a variety of signaling pathways, including MAPK/AP-1. In this study, we examined the time course of EGFR phosphorylation and AP-1 activation in mouse epidermis after topical application of a single 10 nmol dose of TPA. Remarkable differences in the phosphorylation kinetics of EGFR tyrosine residues were observed. While the maximal level of Y1068 tyrosine phosphorylation occurred 4h after TPA treatment, the Y1173 residue phosphorylation was initially down-regulated, and reached the highest level after 24 h. Phosphorylation of Y1068 tyrosine was correlated with AP-1 activation and c-Jun N-terminal kinase (JNK) activity. These results indicate that the stimulation of AP-1 in mouse epidermis by TPA may be the effect of EGFR activation, but not all tyrosine residues forming its catalytic center are equally involved in this process.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22196048     DOI: 10.1016/j.etap.2011.09.005

Source DB:  PubMed          Journal:  Environ Toxicol Pharmacol        ISSN: 1382-6689            Impact factor:   4.860


  2 in total

1.  The effect of resveratrol and its methylthio-derivatives on EGFR and Stat3 activation in human HaCaT and A431 cells.

Authors:  Michal Cichocki; Hanna Szaefer; Violetta Krajka-Kuźniak; Wanda Baer-Dubowska
Journal:  Mol Cell Biochem       Date:  2014-07-26       Impact factor: 3.396

2.  Modulation of P1 and EGF expression by Baicalin.

Authors:  Yanli Meng; Jinhai Huo; Weihong Lu; Xin Wang; Junwei Zhang; Weiming Wang
Journal:  Int J Mol Sci       Date:  2012-12-20       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.